Effects of all‐trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia
Open Access
- 10 August 2004
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 2 (8), 1341-1350
- https://doi.org/10.1111/j.1538-7836.2004.00787.x
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocolBlood, 2002
- Molecular Mechanisms Linking Thrombosis and Angiogenesis in CancerTrends in Cardiovascular Medicine, 1997
- Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acidLeukemia & Lymphoma, 1996
- Rapid improvement of coagulopathy by all‐trans retinoic acid in acute promyelocytic leukemiaAmerican Journal of Hematology, 1994
- New Insights into the Pathogenesis of Coagulation Dysfunction in Acute Promyelocytic LeukemiaLeukemia & Lymphoma, 1993
- Autocrine growth factors and leukaemic haemopoiesisBlood Reviews, 1992
- The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locusNature, 1990
- The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u‐PA rather than defibrinationBritish Journal of Haematology, 1989
- Acute promyelocytic leukemia in 57 previously untreated patientsCancer, 1985
- Acute promyelocytic leukemiaAmerican Journal of Hematology, 1979